Author: Press Release

Washington, DC, September 11, 2019 — (AAFRPS) Virtual reality makeover apps and photo filters can be loads of fun. Who wouldn’t want to see what they may look like with a smaller nose, fuller lips or a blemish-free complexion?  Why not try on that new lipstick shade before you buy it while in the comfort of your own home? These apps and filters are all the rage and for some users, they can be fun, fulfilling and even help them to visualize a potential new look and express their desires to a board-certified facial plastic surgeon during a consultation. But there may be…

Washington, D.C., July 24, 2019—(FDA) The U.S. Food and Drug Administration today took significant action to protect women from breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) by requesting that Allergan, the manufacturer of a specific type of textured implant, recall specific models of its textured breast implants from the U.S. market due to the risk of BIA-ALCL. Following the agency’s request, Allergan has notified the FDA that it is moving forward with a worldwide recall of their BIOCELL textured breast implant products, including: Natrelle Saline-Filled breast implants, Natrelle Silicone-Filled breast implants, Natrelle Inspira Silicone-Filled breast implants, and Natrelle 410 Highly…

Ottawa, May 28, 2019–(Health Canada) Information update Health Canada suspends Allergan’s licences for its Biocell breast implants after safety review concludes an increased risk of cancer Starting date: May 28, 2019Type of communication: Information UpdateSubcategory: Medical DeviceSource of recall: Health CanadaIssue: Important Safety InformationAudience: General Public, Healthcare ProfessionalsIdentification number: RA-70045 Last updated: 2019-05-28 Media enquiriesPublic enquiries OTTAWA – Health Canada has completed an update to a 2017 safety review on breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) and has found that the rate of BIA-ALCL in Canada is significantly higher in patients with macro-textured breast implants compared to other implants. As a result,…

NEW ORLEANS, May 19, 2019 / PRNewswire / — The Aesthetic Surgery Education and Research Foundation (ASERF) announced the election of Robert Whitfield, MD, a plastic surgeon practicing in West Lake Hills, Texas as its new President. Dr. Whitfield is an aesthetic and reconstructive plastic surgeon certified by the American Board of Plastic Surgery.  ASERF is the philanthropic research and education arm of the American Society for Aesthetic Plastic Surgery (The Aesthetic Society). As President of ASERF, Dr. Whitfield plans to continue work on initiatives including extensive research pertaining to Breast Implant Illness (BII) and other breast implant-related issues, following The Aesthetic Society’s and ASERF’s recent successes…

Washington, D.C., May 02, 2019—(FDA) There has been a growing discussion in recent months around the safety of certain breast implants, with regulatory agencies around the world weighing the risk of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). It’s an issue that has been a priority for us at the U.S. Food and Drug Administration since 2011 when we warned women that the available information at the time indicated that there is a risk for women with breast implants, especially those with textured implants, for developing this disease. Since that time, we have worked diligently to fill the gaps in…